Salarius Pharmaceuticals, Inc. (DCOY)
NASDAQ · Healthcare
Salarius Pharmaceuticals, Inc. Net Income 2015–2022
Salarius Pharmaceuticals, Inc. annual/quarterly net income history and growth rate from 2015 to 2023. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Salarius Pharmaceuticals, Inc. net income for the quarter ending March 31, 2023 was -5.3 M, a 12.58% decrease year-over-year.
- Salarius Pharmaceuticals, Inc. net income for the twelve months ending March 31, 2023 was -30.6 M, a 194.58% increase year-over-year.
- Salarius Pharmaceuticals, Inc. annual net income for 2022 was -31.6 M, a 147.55% increase from 2021.
- Salarius Pharmaceuticals, Inc. annual net income for 2021 was -12.8 M, a 73.66% increase from 2020.
- Salarius Pharmaceuticals, Inc. annual net income for 2020 was -7.4 M, a 6.00% increase from 2019.
- Salarius Pharmaceuticals, Inc. annual net income for 2019 was -6.9 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Salarius Pharmaceuticals, Inc. Net Income — FAQ
Salarius Pharmaceuticals, Inc. (DCOY) net income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Salarius Pharmaceuticals, Inc.'s net income?
Salarius Pharmaceuticals, Inc. (DCOY) reported net income of -$32M for fiscal 2022.
Where can I see DCOY's net income history?
The chart and table above show Salarius Pharmaceuticals, Inc.'s net income by year and by quarter, including the growth rate.